FABP5 and breast carcinoma: In accordance, it has been shown that RA inhibits the growth of mammary carcinomas that express a high CRABP-II/FABP5 ratio but facilitates proliferation of mammary carcinomas in which this ratio is low [5, 13, 15, 19].